Cargando…
1037. Effect of Oral Step-Down Therapy on Readmission Rates in Escherichia coli Bacteremia
BACKGROUND: Escherichia coli is the most common cause of community-acquired bloodstream infections. Fluoroquinolones (FQ) and trimethoprim/sulfamethoxazole (TS) are preferred for oral step-down therapy due to high bioavailability. Antimicrobial stewardship programs commonly restrict FQ use, promotin...
Autores principales: | Sessa, Julia, Conn, Kelly M, Avery, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253547/ http://dx.doi.org/10.1093/ofid/ofy210.874 |
Ejemplares similares
-
222. Oral Step-Down Therapy for Uncomplicated Enterococcus Bacteremia
por: Ni, Jessica, et al.
Publicado: (2023) -
726 Readmission rate associated with Staphylococcus aureus bacteremia
por: Lee, Jean, et al.
Publicado: (2014) -
1037 The risk factors for resistant Esherichia coli infections after prostate biopsy under fluoroquinolone prophylaxis
por: Kandemir, Özlem, et al.
Publicado: (2014) -
1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019) -
1114. Oral β-lactams for the Treatment of Escherichia coli Bacteremia Secondary to Complicated Urinary Tract Infections Including Pyelonephritis
por: Harrington, Nicole, et al.
Publicado: (2019)